ÂÜÀòÂÒÂ×

Flemming Nissen serves as a Senior Clinical Business Process Manager at Genmab since January 2023, previously worked as an Independent Consultant at Acumen Capacity from September 2021 to November 2022, and held several roles at LEO Pharma from May 2012 to June 2019, including Senior Clinical Project Manager, where responsibilities included setting up a complex phase IV trial on biologic treatment for psoriasis, as well as roles focused on operational planning and analytics. Prior experience includes positions at Eli Lilly and Company between August 2006 and May 2012, where Flemming Nissen engaged in clinical development across several therapeutic areas, and earlier experience at NCC/Aarsleff Tanzania. Flemming Nissen holds a Master of Science in Biotechnology from the Technical University of Denmark and completed secondary education at Gladsaxe Gymnasium.